CONCLUSION: The SPHK-S1P signaling axis is a core pathway driving sphingolipid metabolic dysregulation in the prefrontal cortex in ADHD. Targeted inhibition of this pathway synergistically modulates the expression levels of proteins associated with dopaminergic neurotransmission. The limited regulatory effect of taVNS on sphingolipid metabolism suggests its clinical benefits may stem from multi-pathway synergistic mechanisms.
